Skip to main content
Market intelligence
EDITHealthcare

Editas Medicine Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 3, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 3, 2026Amy ParisonSVP, Chief Financial OfficerSale678$2.58$1,749
Jul 28, 2026Linda BurklyEVP, CHIEF SCIENTIFIC OFFICERSale4,928$2.67$13,158
Jun 3, 2026Amy ParisonSVP, Chief Financial OfficerSale464$2.70$1,253